Browse > Article
http://dx.doi.org/10.11628/ksppe.2018.21.6.485

Development of Highly Sensitive Analytical Method for Evaluation of Evening Primrose Oil's Enhancing Effect in Prostaglandin E1(OP 1206) Biosynthesis  

Lee, Sung-Hoon (Department of Pharmaceutical-Biomedical Engineering, College of Engineering, Cheongju University)
Publication Information
Journal of People, Plants, and Environment / v.21, no.6, 2018 , pp. 485-492 More about this Journal
Abstract
This study aimed to develop and validate highly sensitive determination method of a prostaglandin ($PGE_1$, OP 1206) in human plasma by LC-MS/MS using column switching. Plasma stored at $-30^{\circ}C$ and treated with methanol effectively inhibited interferences synthesized post-sampling. Samples were added with internal standard and were separated by reversed-phase HPLC with a cycle time of 30min. The method was selective for OP 1206 and the regression models, based on internal standard, were linear across the concentration range 0.5-50 pg/mL with the limit of quantification of 0.5 pg/mL (limit of quantitation, LOQ) for OP 1206. The calibration curve of OP 1206 standards spiked in five individual plasma samples was linear ($r^2=0.9999$). Accuracy and precision at the concentrations of 0.5, 1.5, 5.0 and 40 pg/mL, and at the lower LOQ of 0.5 pg/mL were excellent at 20%. OP120 < 6 was stable in plasma samples for at least 24 hours at room temperature, 24 hours frozen at $-70^{\circ}C$, 24 hours in an auto sampler at $6^{\circ}C$, and for two freeze/unfreezing cycles. The validated determination method successfully quantified the concentrations of OP 1206 in plasma samples from simulated administrating a single $5{\mu}g$ OP 1206 formulation. Thus, this novel LC-MS/MS technique for drug separation, detection and quantitation is expected to become the standard highly-sensitive detection method in bioanalysis and to be applied to many low dose pharmaceutical products.
Keywords
analytical validation; evening primrose oil; LC-MS/MS; Prostaglandin $E_1$;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Atikinson, H. C., I. Stanescu, C. Frampton, I.I. Salem, C.P. Beasley, and R. Robson. 2015. Pharmacokinetics and bioavailability of a fixed-dose combination of ibuprofen and paracetamol after intravenous and oral administration. Clin. Drug Investig. 35(10):625-632. DOI:10.1007/s40261-015-0320-8   DOI
2 Food and Drug Administration. 2018. Guidance for industry, bioanalytical method validation. Silver Spring, MD: US Department of Health and Human Services. Center for Drug Evaluation and Research(CDER). Retrieved from https://www.fda.gov/downloads/drugs/guid ances/ucm070107.pdf
3 Fujitani, B., M. Watanabe, J. Kuwashima, T. Tsuboi, T. Kadokawa, and T. Kitagawa. 1986. Effect of a prostaglandin E1 derivative (OP-1206) and acetylsalicylic acid on electrically induced thrombosis in guinea-pig mesenteric artery and its modification by an inhibitor of prostaglandin I2 synthetase, tranylcypromine. Jpn. J. Pharmacol. 40(1):31-35. DOI:10.1254/jjp.40.31   DOI
4 Inoue, Y., N. Sekiya, K. Katayama, S. Narutaki, M. Yamamoto, D. Iohara, F Hirayama, and K. Uekama. 2014. Stabilizing effect of ${\beta}$-Cyclodextrin on Limaprost, a PGE1 Derivative, in Limaprost Alfadex Tablets (Opalmon(R)) in highly humid conditions. Chem. Pharm. Bull. 62(8):786-792. DOI:10.1248/cpb.c14-00150   DOI
5 Steuer, A.E., A.M. Forss, A.M. Dally, and T. Kraemer. 2014. Method development and validation for simultaneous quantification of 15 drugs of abuse and prescription drugs and 7 of their metabolites in whole blood relevant in the context of driving under the influence of drugs-Usefulness of multi-analyte calibration. Forensic Sci. Int. 244:92-101. DOI: 10.1016/j.forsciint.2014.08.022   DOI
6 Komaba, J., Y. Masuda, Y. Hashimoto, S. Nago, M, Takamoto, K. Shibakawa, S. Nakade, and Y. Miyata. 2007. Ultra sensitive determination of limaprost, a prostaglandin E1 analogue, in human plasma using on-line two-dimensional reversed-phase liquid chromatography-tandem mass spectrometry. J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 852:590-597. DOI:10.1016/j.jchromb.2007.02.031   DOI
7 Lee, K.J., H.J. Yang, and J.Y. Ma. 2014. Simultaneous analysis of 12 kind maker components in Banhabaekchulchhonmatang by RP-HPLC. J. Korea Acad. Ind. Coop. Soc. 15(7):4682-4691. DOI:10.5762/KAIS.2014.15.7.4682
8 Malone, J. and L. Hughes. 2014. An HPLC-MS/MS method for the determination of oxycodone, noroxycodone & oxymorphone in human plasma. Craigavon, United Kingdom: Almac Sciences. DOI:10.13140/RG.2.1.5059.0242   DOI
9 Omran, O.M. 2012. Histopathological study of evening primrose oil effects on experimental diabetic neuropathy. Ultrastruct. Pathol. 36(4):222-227. DOI:10.3109/01913123.2012.662268   DOI
10 Rodgers, A., S. Lewandoski, S. Allie-Hamdulay, D. Pinnock, G. Baretta, and G. Gambaro. 2009. Evening primrose oil supplementation increases citraturia and decreases other urinary risk factors for calcium oxalate urolithiasis. J. Urol. 182(6):2957-2963. DOI:10.1016/j.juro.2009.08.021   DOI
11 Swainston Harrison, T., and G.L. Plosker. 2007. Limaprost. Drugs 67(1):109-118. DOI:10.2165/00003495-200767010-00010   DOI
12 Zimmerman, D.C., and P. Feng. 1978. Characterization of a prostaglandin-like metabolite of linolenic acid produced by a flaxseed extract. Lipids 13(5): 313-316. DOI:10.1007/BF02533720   DOI
13 Tsuboi, T., B. Fujitani, J. Maeda, K. Yoshida, M. Shimizu, A. Kawasaki, T. Okegawa, and M. Tsuboshima. 1980. Effect of OP-1206, a prostaglandin E1 derivative, on guinea-pig platelet functions. Thromb. Res. 15(5-6):573-580. DOI: 10.101 6/0049-3848(80)90145-0   DOI
14 Wettasinghe, M., F. Shahidi, and R. Amarowicz. 2002. Identification and quantification of low molecular weight phenolic antioxidants in seeds of evening primrose (Oenothera biennis L.). J. Agric. Food Chem. 50(5):1267-1271. DOI: 10.102 1/jf010526i   DOI